|
1.
|
|
14 p, 1.3 MB |
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials
/
Sforzini, Luca (King's College London) ;
Worrell, Courtney (King's College London) ;
Kose, Melisa (King's College London) ;
Anderson, Ian M. (The University of Manchester and Manchester Academic Health Sciences Centre) ;
Aouizerate, Bruno (University of Bordeaux) ;
Arolt, Volker (University of Münster) ;
Bauer, Michael (University Hospital Carl Gustav Carus) ;
Baune, Bernhard T. (The University of Melbourne) ;
Cleare, Anthony J. (National Institute for Health Research Mental Health Biomedical Research Centre) ;
Cowen, Philip J. (University of Oxford) ;
Dinan, Timothy G. (University College Cork) ;
Fagiolini, Andrea (University of Siena) ;
Ferrier, I. Nicol (Newcastle University) ;
Hegerl, Ulrich (Goethe University) ;
Krystal, Andrew D. (Duke University School of Medicine) ;
Leboyer, Marion (Université Paris Est Creteil (UPEC)) ;
McAllister-Williams, R. Hamish (Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust) ;
McIntyre, Roger S. (Brain and Cognition Discovery Foundation) ;
Meyer-Lindenberg, Andreas (Heidelberg University) ;
Miller, Andrew H. (Emory University School of Medicine) ;
Nemeroff, Charles B. (University of Texas at Austin) ;
Normann, Claus (Medical Center - University of Freiburg) ;
Nutt, David (Imperial College) ;
Pallanti, Stefano (University of Florence) ;
Pani, Luca (VeraSci) ;
Penninx, Brenda W. J. H. (Vrije Universiteit and GGZinGeest) ;
Schatzberg, Alan F. (Stanford University) ;
Shelton, Richard C. (University of Alabama at Birmingham) ;
Yatham, Lakshmi N. (University of British Columbia) ;
Young, Allan H. (National Institute for Health Research Mental Health Biomedical Research Centre) ;
Zahn, Roland (National Institute for Health Research Mental Health Biomedical Research Centre) ;
Aislaitner, Georgios (Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM)) ;
Butlen-Ducuing, Florence (European Medicines Agency) ;
Fletcher, Christine (Biostatistics, GlaxoSmithKline) ;
Haberkamp, Marion (Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM)) ;
Laughren, Thomas (Laughren Psychopharm Consulting) ;
Mäntylä, Fanni-Laura (GAMIAN-Europe (Global Alliance of Mental Illness Advocacy Networks-Europe)) ;
Schruers, Koen (University of Leuven) ;
Thomson, Andrew (European Medicines Agency) ;
Arteaga-Henríquez, Gara (Hospital Universitari Vall d'Hebron) ;
Benedetti, Francesco (IRCCS Scientific Institute Ospedale San Raffaele) ;
Cash-Gibson, Lucinda (Hospital Universitari Vall d'Hebron) ;
Chae, Woo Ri (Charité - Universitätsmedizin Berlin) ;
De Smedt, Heidi (Janssen Research & Development) ;
Gold, Stefan M. (University Medical Center Hamburg-Eppendorf) ;
Hoogendijk, Witte J. G. (Erasmus University Medical Centre) ;
Mondragón, Valeria Jordán (Medical Director Neuroscience for Region Europe at Novartis Pharma) ;
Maron, Eduard (West Tallinn Central Hospital) ;
Martynowicz, Jadwiga (Janssen Research & Development) ;
Melloni, Elisa (IRCCS Scientific Institute Ospedale San Raffaele) ;
Otte, Christian (Charité - Universitätsmedizin Berlin) ;
Perez-Fuentes, Gabriela (Hospital Universitari Vall d'Hebron) ;
Poletti, Sara (IRCCS Scientific Institute Ospedale San Raffaele) ;
Schmidt, Mark E. (Janssen Pharmaceutica NV) ;
van de Ketterij, Edwin (European Infrastructure for Translational Medicine (EATRIS)) ;
Woo, Katherine (Janssen Research & Development) ;
Flossbach, Yanina (Novartis Pharma AG) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron) ;
Savitz, Adam J. (Department of Neuroscience) ;
Pariante, Carmine M (National Institute for Health Research Mental Health Biomedical Research Centre) ;
Universitat Autònoma de Barcelona
Criteria for treatment-resistant depression (TRD) and partially responsive depression (PRD) as subtypes of major depressive disorder (MDD) are not unequivocally defined. In the present document we used a Delphi-method-based consensus approach to define TRD and PRD and to serve as operational criteria for future clinical studies, especially if conducted for regulatory purposes. [...]
2021 -  10.1038/s41380-021-01381-x
Molecular psychiatry, Vol. 27 (december 2021) , p. 1286-1299
|
|
|
2.
|
|
18 p, 528.6 KB |
Deaths of Despair : A Scoping Review on the Social Determinants of Drug Overdose, Alcohol-Related Liver Disease and Suicide
/
Beseran, Elisabet (Universitat Pompeu Fabra) ;
Pericàs, Juan M. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Cash-Gibson, Lucinda (Universitat Pompeu Fabra) ;
Ventura-Cots, Meritxell (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Porter, Keshia M. Pollack (Johns Hopkins Bloomberg School of Public Health) ;
Benach, Joan (Universidad Autónoma de Madrid) ;
Universitat Autònoma de Barcelona
Background: There is a lack of consensus on the social determinants of Deaths of Despair (DoD), i. e. , an increase in mortality attributed to drug overdose, alcohol-related liver disease, and suicide in the United States (USA) during recent years. [...]
2022 - 10.3390/ijerph191912395
International journal of environmental research and public health, Vol. 19 (september 2022)
|
|
|
3.
|
|
5 p, 665.0 KB |
Health Inequalities in the Time of COVID-19 : The Globally Reinforcing Need to Strengthen Health Inequalities Research Capacities
/
Cash-Gibson, Lucinda (Universitat Pompeu Fabra) ;
Pericàs, Juan M. (Hospital Universitari Vall d'Hebron) ;
Martinez-Herrera, Eliana (University of Antioquia) ;
Benach, Joan (Universidad Autónoma de Madrid) ;
Universitat Autònoma de Barcelona
The full impact of coronavirus disease 2019 (COVID-19) is yet to be well established; however, as the pandemic spreads, and early results emerge, unmet needs are being revealed, and pressing questions are being asked about who is most affected, how, where, and in what ways government responses might be exacerbating inequalities. [...]
2021 - 10.1177/0020731421993939
International journal of health services, Vol. 51 (march 2021) , p. 300-304
|
|
|
5.
|
|
12 p, 1.4 MB |
Evaluation of the mortality registry in Ecuador (2001-2013) - social and geographical inequalities in completeness and quality
/
Peralta Chiriboga, Alejandro Andrés (Universitat Pompeu Fabra) ;
Benach, Joan (Universidad Autónoma de Madrid. Grupo de Investigación Transdisciplinar sobre Transiciones Socioecológicas (GinTRANS2)) ;
Borrell i Thió, Carme (Institut d'Investigació Biomèdica Sant Pau) ;
Espinel-Flores, Verónica (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ;
Cash-Gibson, Lucinda (Universitat Pompeu Fabra) ;
Queiroz, Bernardo L. (Department of Demography and Cedeplar, Faculdade de Ciências Econômicas, FACE/UFMG, Campus Pampulha, Av. Antônio Carlos, 6627, Pampulha, Belo Horizonte, MG CEP 31270-901 Brazil) ;
Marí-Dell'Olmo, Marc 1978- (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
Mortality registries are an essential data source for public health surveillance and for planning and evaluating public policy. Nevertheless, there are still large inequalities in the completeness and quality of mortality registries between and within countries. [...]
2019 - 10.1186/s12963-019-0183-y
Population Health Metrics, Vol. 17 (march 2019)
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
